(Q53890793)

English

The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit